1. Home
  2. GWAV vs PHGE Comparison

GWAV vs PHGE Comparison

Compare GWAV & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GWAV
  • PHGE
  • Stock Information
  • Founded
  • GWAV 2002
  • PHGE 2015
  • Country
  • GWAV United States
  • PHGE Israel
  • Employees
  • GWAV N/A
  • PHGE N/A
  • Industry
  • GWAV Packaged Foods
  • PHGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • GWAV Consumer Staples
  • PHGE Health Care
  • Exchange
  • GWAV Nasdaq
  • PHGE Nasdaq
  • Market Cap
  • GWAV 10.9M
  • PHGE 11.0M
  • IPO Year
  • GWAV N/A
  • PHGE N/A
  • Fundamental
  • Price
  • GWAV $0.19
  • PHGE $0.45
  • Analyst Decision
  • GWAV
  • PHGE Strong Buy
  • Analyst Count
  • GWAV 0
  • PHGE 1
  • Target Price
  • GWAV N/A
  • PHGE $15.00
  • AVG Volume (30 Days)
  • GWAV 1.2M
  • PHGE 286.6K
  • Earning Date
  • GWAV 08-18-2025
  • PHGE 08-13-2025
  • Dividend Yield
  • GWAV N/A
  • PHGE N/A
  • EPS Growth
  • GWAV N/A
  • PHGE N/A
  • EPS
  • GWAV N/A
  • PHGE N/A
  • Revenue
  • GWAV $33,315,859.00
  • PHGE N/A
  • Revenue This Year
  • GWAV N/A
  • PHGE N/A
  • Revenue Next Year
  • GWAV N/A
  • PHGE N/A
  • P/E Ratio
  • GWAV N/A
  • PHGE N/A
  • Revenue Growth
  • GWAV N/A
  • PHGE N/A
  • 52 Week Low
  • GWAV $0.12
  • PHGE $0.34
  • 52 Week High
  • GWAV $1.88
  • PHGE $3.86
  • Technical
  • Relative Strength Index (RSI)
  • GWAV 48.08
  • PHGE 43.76
  • Support Level
  • GWAV $0.19
  • PHGE $0.43
  • Resistance Level
  • GWAV $0.20
  • PHGE $0.48
  • Average True Range (ATR)
  • GWAV 0.01
  • PHGE 0.04
  • MACD
  • GWAV -0.00
  • PHGE 0.00
  • Stochastic Oscillator
  • GWAV 41.64
  • PHGE 60.59

About GWAV Greenwave Technology Solutions Inc.

Greenwave Technology Solutions Inc through its subsidiary, is an operator of several metal recycling facilities in Virginia, Ohio and North Carolina. At these facilities, the company is involved in collecting, classifying, and processing raw scrap metal (ferrous and nonferrous) for recycling. The company involves collecting, classifying and processing appliances, construction material, end-of-life vehicles, boats, and industrial machinery and processing those items by crushing, shearing, shredding, separating, and sorting, into smaller pieces and categorize these recycled ferrous, nonferrous, and mixed metal pieces based on density and metal prior to sale.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is engaged in developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. It discovers and validates proprietary bacterial targets and customizes phage compositions against these targets, and applies its BOLT (BacteriOphage Lead to Treatment) platform to customize phage compositions against these targets. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF. Its BX211 - Treatment of Diabetic Foot Osteomyelitis (DFO).

Share on Social Networks: